تخطَّ إلى المحتوى
دليل الأدوية المصري
تابع آخر تحديثات الأسعار على واتساب

سعر بروبيس 10مجم غسول مهبلي 2022

Propess 10 mg vaginal delivery system

معلومات الدواء

التفاصيل الكاملة
عن الدواءAbout the medicine

Dinoprostone (prostaglandin E2) 10 mg vaginal delivery system releasing about 0.3 mg/hour, for cervical ripening at term.

Dinoprostone (prostaglandin E2) 10 mg vaginal delivery system releasing about 0.3 mg/hour, for cervical ripening at term.

دواعي الاستعمالUses
  • Initiation of cervical ripening at term (from 37 completed weeks of gestation)الفئة: Pregnant women at termelectronic medicines compendium (emc)
  • Initiation of cervical ripening at term (from 37 completed weeks of gestation)Population: Pregnant women at termelectronic medicines compendium (emc)
الآثار الجانبيةSide effects
  • Most common: fetal heart rate disorder, abnormal uterine contractions and abnormal labour affecting the fetus; also uterine hyperstimulation/tachysystole, nausea, vomiting, hypotension; post-marketing DIC, anaphylaxis and uterine rupture.نشرة دولية لنفس المنتج · electronic medicines compendium (emc)
  • Most common (≥2%) with the US 10 mg insert: uterine tachysystole with or without fetal distress, and fetal distress without tachysystole.نشرة دولية لنفس التركيبة · DailyMed (US NLM)
  • Most common: fetal heart rate disorder, abnormal uterine contractions and abnormal labour affecting the fetus; also uterine hyperstimulation/tachysystole, nausea, vomiting, hypotension; post-marketing DIC, anaphylaxis and uterine rupture.International label, same product · electronic medicines compendium (emc)
  • Most common (≥2%) with the US 10 mg insert: uterine tachysystole with or without fetal distress, and fetal distress without tachysystole.International label, same formulation · DailyMed (US NLM)
موانع الاستعمالContraindications
  • Labour started; oxytocic or other induction agents being given; previous major uterine or cervical surgery (e.g. caesarean section); cephalopelvic disproportion; fetal malpresentation; suspected fetal distress; untreated pelvic inflammatory disease; hypersensitivity; placenta praevia or unexplained vaginal bleeding.نشرة دولية لنفس المنتج · electronic medicines compendium (emc)
  • Labour started; oxytocic or other induction agents being given; previous major uterine or cervical surgery (e.g. caesarean section); cephalopelvic disproportion; fetal malpresentation; suspected fetal distress; untreated pelvic inflammatory disease; hypersensitivity; placenta praevia or unexplained vaginal bleeding.International label, same product · electronic medicines compendium (emc)
تحذيرات واحتياطاتWarnings & precautions
  • Uterine rupture reported, mainly with contraindicated conditions; caution with history of uterine hypertonus, glaucoma, asthma, ruptured membranes, multiple pregnancy, >3 full-term deliveries; increased DIC risk in women ≥35 years or with pregnancy complications; stop NSAIDs including aspirin before use.نشرة دولية لنفس المنتج · electronic medicines compendium (emc)
  • Uterine rupture reported, mainly with contraindicated conditions; caution with history of uterine hypertonus, glaucoma, asthma, ruptured membranes, multiple pregnancy, >3 full-term deliveries; increased DIC risk in women ≥35 years or with pregnancy complications; stop NSAIDs including aspirin before use.International label, same product · electronic medicines compendium (emc)
التداخلات الدوائيةDrug interactions
  • Oxytocic drugs (e.g. oxytocin)Prostaglandins potentiate the uterotonic effect of oxytocics; do not use concurrently.electronic medicines compendium (emc)
  • Oxytocic drugs (e.g. oxytocin)Prostaglandins potentiate the uterotonic effect of oxytocics; do not use concurrently.electronic medicines compendium (emc)
الحمل والرضاعةPregnancy & breastfeeding
  • Should not be used before 37 completed weeks of gestation.نشرة دولية لنفس المنتج · electronic medicines compendium (emc)
  • May pass into colostrum/breast milk at very limited levels; not expected to hinder breastfeeding.نشرة دولية لنفس المنتج · electronic medicines compendium (emc)
  • Should not be used before 37 completed weeks of gestation.International label, same product · electronic medicines compendium (emc)
  • May pass into colostrum/breast milk at very limited levels; not expected to hinder breastfeeding.International label, same product · electronic medicines compendium (emc)
كيف يعمل الدواءHow it works
  • PGE2 promotes cervical ripening (collagenase activation and collagen breakdown), transforming the cervix from rigid to soft and dilated.
  • Dinoprostone: PGE2 promotes cervical ripening (collagenase activation and collagen breakdown), transforming the cervix from rigid to soft and dilated.

المعرّفات

تصنيف ATC

المصادر

تعليقات

لا توجد تعليقات بعد. كن أول من يشارك تجربته مع هذا الدواء.

أضف تعليقًا

0/60

لا يُنشر أبدًا؛ للتواصل فقط إن لزم.

0/1000

من 20 إلى 1000 حرف. بدون روابط.

التعليقات للمعلومات العامة ولا تُعد نصيحة طبية. لا تذكر بيانات شخصية.